Navigation Links
Amyris Chief Joins Renmatix BoD, New CFO Added to Company
Date:9/14/2011

KENNESAW, Ga., Sept. 14, 2011 /PRNewswire/ -- Renmatix, the leading producer of cellulosic sugars, is pleased to announce John Melo, CEO of renewable chemical and fuels company Amyris, has joined the Renmatix Board of Directors. Ellen Purdy, who last year was named "CFO of the Year" by the Philadelphia Business Journal, will fill the chief financial officer role as the company expands operations.

Melo comes to the Renmatix Board of Directors with rare perspective gained from launching one of the bioindustry's most watched companies. Melo began his career in energy markets at British Petroleum, where he most recently served as President of US Fuels Operations.

"Ask any of my colleagues in this bioindustry what they most need to succeed and they'll tell you: we need reliable sources of cost effective cellulosic sugar," said Melo. "Renmatix is delivering that sugar sustainably, with very attractive economics and taking the guesswork out of the bioindustrial supply chain."

Prior to joining Renmatix, Ellen Purdy served as CFO for SDI, serving the pharmaceutical and biotech markets. She brings more than a decade of chemical business experience to the company. Purdy's academic credentials include a B.S. from the Wharton School of Business at University of Pennsylvania, and an M.B.A. from Northwestern University.

"As a business person, I find Renmatix exciting because it's every bit as focused on economics as it is on technology," said Purdy. "I look forward to making the most of Renmatix's unique financial opportunities as we change the economics of cellulosic sugar."

Mike Hamilton, CEO of Renmatix, commented, "We are thrilled to have these two outstanding individuals join the Renmatix team. The additions position us for continued success and further reinforce our excitement in the company and the value Renmatix brings to the renewable materials business."

About Renmatix
Renmatix is the leading producer of cellulosic sugars for the global renewable chemical and fuels markets. The company's proprietary Plantrose™ process challenges conventional sugar economics by cheaply converting biomass – from woody biomass to agricultural residue – into useful, cost-effective sugars. Renmatix technology deconstructs non-food biomass an order of magnitude faster than other processes and enhances its cost advantage by using no significant consumables. Backed by Kleiner Perkins Caufield & Byers, Renmatix is privately held, with operations in Georgia currently capable of converting three dry tons of cellulosic biomass to sugar per day. For more information, please visit www.renmatix.com.

Media contact:
Katie Struble
Antenna Group for Renmatix
renmatix@antennagroup.com
415-977-1928


'/>"/>
SOURCE Renmatix
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
2. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
3. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
4. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
5. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
6. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
7. Algenol Biofuels Appoints Chief Science Officer
8. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
9. Chief Technology Officer Joins ACAMP
10. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
11. LS9, Inc. Appoints Bill Haywood Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... Scientists at the University of Athens ... for mesothelioma may be hampering the research that could lead to one good one. ... to read it now. , The team evaluated 98 mesothelioma patients ...
(Date:5/25/2016)... Connecticut (PRWEB) , ... May 25, 2016 , ... ... the U.S. Food and Drug Administration (FDA) has granted the company’s orphan drug ... the company’s second orphan drug designation granted by the FDA. , Spinocerebellar ...
(Date:5/24/2016)... La Jolla, CA (PRWEB) , ... May 24, 2016 , ... ... and financial planning for corporate executives and entrepreneurs, held The Future of San Diego ... leaders in the San Diego life science community attended the event with speakers Dr. ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media has ... 2017 and Beyond. The paper outlines the key trends that are creating both ... “We’ve witnessed a lot of highs and lows as the precision agriculture market ...
Breaking Biology Technology:
(Date:3/21/2016)... -- Unique technology combines v ...   Xura, Inc. (NASDAQ: ... communications services, today announced it is working alongside SpeechPro ... particularly those in the Financial Services Sector, the ability ... a mobile app, alongside, and in combination with, traditional ...
(Date:3/15/2016)... -- Yissum Research Development Company of the Hebrew ... Hebrew University, announced today the formation of Neteera ... human biological indicators. Neteera Technologies has completed its first ... ... emissions from sweat ducts, enables reliable and speedy biometric ...
(Date:3/11/2016)... -- --> --> ... Market by Technology (Pattern Recognition), by Component (Hardware, Software, ... (On-Premises and Cloud), by Industry Vertical and by Region ... global market is expected to grow from USD 12.49 ... at a CAGR of 19.1%. , ...
Breaking Biology News(10 mins):